Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

MA01.09 Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504)

S. Khan,Z. Sun,R. Pillai,S. Dahlberg,J. Malhotra,R. Keresztes,C. Ikpeazu,P. Ma,S. Ramalingam

Journal of Thoracic Oncology（2021）

Cited 4|Views6
No score
Abstract
Glycoprotein nmb (gp-NMB) is a transmembrane protein expressed in a variety of cancers; it has been linked with poor prognosis. The majority of patients with squamous lung cancer have high cellular expression of gp-NMB. Glembatumumab vedotin is an antibody-drug conjugate targeting gp-NMB.
More
Translated text
Key words
glembatumumab vedotin,metastatic squamous cell carcinoma,squamous cell carcinoma,lung
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined